Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: Aspidos; MMH 18; MMH 8 for paediatric use - Millenia Hope; MMH Malarex; Vocamine

Latest Information Update: 17 Apr 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Millenia Hope
  • Class Antimalarials; Indole alkaloids
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Market Withdrawal Malaria

Most Recent Events

  • 13 Sep 2005 Launched for Malaria in Cameroon (PO)
  • 25 Aug 2005 Millenia Hope and Coca Cola have entered into an agreement to conduct a pilot programme of voacamine in Guinea Conakry, West Africa, for malaria
  • 25 Aug 2005 Millenia Hope has initiated enrolment of 200 patients in a pilot programme for malaria in Guinea Conakry, West Africa
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top